TFG Asset Management’s RAPT Therapeutics RAPT Stock Holding History

TFG Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-131,770	Closed	-$4.46M	–	39
2025 Q4	$4.46M	Buy	+131,770	New	+$4.09M	0.94%	15

TFG Asset Management's RAPT Position: Q1 2026 in Review

TFG Asset Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 131,770 shares — an estimated $4.46M sold.

TFG Asset Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $4.46M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

TFG Asset Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
TFG Asset Management sold 131,770 RAPT Therapeutics shares in Q1 2026, an estimated $4.46M.
TFG Asset Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
TFG Asset Management's RAPT Therapeutics position peaked at $4.46M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on TFG Asset Management's 13F filing for Q1 2026, filed 15 May 2026.